April 11, 2012 in New York

  //health-fitness.news-articles.net/content/2012/04/09/april-11-2012-in-new-york.html
  Published in Health and Fitness on Monday, April 9th 2012 at 11:55 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

TPI 2011 Shareholder Annual Meeting Reminder: April 11, 2012 in New York -- CHENGDU, China, April 9, 2012 /PRNewswire-Asia/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about TPI

CHENGDU, China, April 9, 2012 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: [ TPI ]), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced the reminder that the Company's 2011 Annual Shareholder Meeting will be held at Floor 20, 17 State Street, New York, NY 10004 on Wednesday, April 11, 2012, at 10:00 am (EST). February 13, 2012 is the record date for determining the stockholders entitled to vote at the annual meeting. Stockholders as of the record date are welcome to attend the meeting at the address above-mentioned, or dial in at 712-432-0080 (access code: 512917#).

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, mTCM, branded generics and API. TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI's pipeline targets various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about TPI, please visit: [ http://www.tianyinpharma.com ]

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please visit: [ http://www.tianyinpharma.com ], or email [ ir@tpi.asia ].

Tel:  +86-28-8551-6696 (Chengdu, China)
       +86-134-3655-0011 (China)
Address:
Tianyin Pharmaceutical
23rd Floor, Unionsun Yangkuo Plaza     
No. 2, Block 3, South Renmin Road
Chengdu, 610041
China

SOURCE Tianyin Pharmaceutical Co., Inc.

RELATED LINKS
[ http://www.tianyinpharma.com ]